These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 10824628)

  • 1. Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction.
    Fromm MF; Dilger K; Busse D; Kroemer HK; Eichelbaum M; Klotz U
    Br J Clin Pharmacol; 1998 Mar; 45(3):247-55. PubMed ID: 9517368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic study-A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention.
    Chen YC; Wang H; Mandrekar JN; Robertson CE; Starling AJ; Cutrer FM; Chiang CC
    Pharmacogenomics J; 2024 Apr; 24(3):11. PubMed ID: 38594235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants related to successful migraine prophylaxis with verapamil.
    Cutrer FM; Moyer AM; Atkinson EJ; Wang L; Tian S; Wu Y; Garza I; Robertson CE; Huebert CA; Moore BE; Klein CJ
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1680. PubMed ID: 33829662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?
    Alexandre J; Humbert X; Sassier M; Milliez P; Coquerel A; Fedrizzi S
    Drug Saf Case Rep; 2015 Dec; 2(1):13. PubMed ID: 27747725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions with triptans : which are clinically significant?
    Rolan PE
    CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats.
    O'Brien FE; Clarke G; Fitzgerald P; Dinan TG; Griffin BT; Cryan JF
    Br J Pharmacol; 2012 Jun; 166(4):1333-43. PubMed ID: 22250926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almotriptan in the treatment of migraine.
    Sandrini G; Perrotta A; Arce Leal NL; Buscone S; Nappi G
    Neuropsychiatr Dis Treat; 2007 Dec; 3(6):799-809. PubMed ID: 19300615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of the triptans: clinical implications.
    Nappi G; Sandrini G; Sances G
    Drug Saf; 2003; 26(2):93-107. PubMed ID: 12534326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Almotriptan, a new anti-migraine agent: a review.
    Gras J; Llenas J; Jansat JM; Jáuregui J; Cabarrocas X; Palacios JM
    CNS Drug Rev; 2002; 8(3):217-34. PubMed ID: 12353056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.
    Jhee SS; Shiovitz T; Crawford AW; Cutler NR
    Clin Pharmacokinet; 2001; 40(3):189-205. PubMed ID: 11327198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers.
    Fleishaker JC; Sisson TA; Carel BJ; Azie NE
    Clin Pharmacol Ther; 2000 May; 67(5):498-503. PubMed ID: 10824628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effect of almotriptan in treated hypertensive patients.
    Fleishaker JC; McEnroe JD; Azie NE; Francom SF; Carel BJ
    Clin Pharmacol Ther; 2002 Mar; 71(3):169-75. PubMed ID: 11907491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults.
    Baldwin JR; Fleishaker JC; Azie NE; Carel BJ
    Cephalalgia; 2004 Apr; 24(4):288-92. PubMed ID: 15030538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine.
    McEnroe JD; Fleishaker JC
    Clin Pharmacokinet; 2005; 44(3):237-46. PubMed ID: 15762767
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.